Jan 24, 2019 07:08AM
Jan 24, 2019 07:00AM
Nov 8, 2018 06:35AM
Oct 31, 2018 09:46AM
Oct 31, 2018 09:45AM
Sep 20, 2018 07:06AM
Sep 20, 2018 07:00AM FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Clinical Program
Sep 12, 2018 07:04AM
Sep 12, 2018 07:00AM
Aug 9, 2018 04:10PM
Aug 2, 2018 04:05PM
Jul 31, 2018 07:19AM
Jul 31, 2018 07:00AM
Jul 25, 2018 07:00AM Data from BioTime’s OpRegen® Program to Be Presented at AAO 2018
Jul 17, 2018 07:04AM
Jul 17, 2018 07:00AM
Jun 25, 2018 07:00AM
May 29, 2018 07:05AM
May 29, 2018 07:00AM
May 24, 2018 07:00AM
May 10, 2018 04:05PM BioTime Reports First Quarter Results and Recent Corporate Accomplishments
May 1, 2018 08:00AM
Apr 16, 2018 07:00AM
Apr 9, 2018 08:00AM
Mar 15, 2018 04:10PM
Mar 15, 2018 04:05PM
Mar 7, 2018 08:00AM
Mar 1, 2018 09:24AM Pre-Open Movers 03/01: (NVAX) (DDD) (HIIQ) Higher; (PTLA) (PDCO) (BOX) Lower (more...)
Feb 28, 2018 05:56PM
Feb 15, 2018 07:00AM
Jan 22, 2018 07:00AM
Jan 17, 2018 07:08AM
Jan 17, 2018 07:00AM
Jan 4, 2018 07:52AM
Dec 19, 2017 07:00AM Asterias Biotherapeutics Completes Enrollment of Entire SCiStar Study
Dec 4, 2017 08:00AM
Nov 15, 2017 08:00AM
Nov 14, 2017 04:10PM
Nov 9, 2017 04:05PM
Oct 11, 2017 07:06AM
Oct 11, 2017 07:00AM
Oct 2, 2017 07:11AM Asterias (AST) Announced 12-month Data from Efficacy Cohort in Phase 1/2a SCiStar Study of AST-OPC1; Granted RMAT
Oct 2, 2017 07:00AM
Sep 25, 2017 07:06AM
Sep 25, 2017 07:00AM
Sep 14, 2017 05:44PM
Sep 14, 2017 05:43PM
Aug 30, 2017 07:06AM
Aug 30, 2017 07:00AM Preclinical Data Published in Peer-Reviewed Journal Stem Cells Translational Medicine Provides Scientific Framework for Asterias’ AST-OPC1 for the Treatment of Subacute Cervical Spinal Cord Injury
Aug 23, 2017 07:00AM

322,248 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All